CNT’s Medical Director, Indra Cidambi, M.D. comments on the link between genetics and addiction.Continue Reading →
Dr. Cidambi is featured in, “The Hidden Victims of the Opioid Crisis,” an article about the uptick in the number of children in the foster care system as more parents become addicted to opioids. Dr. Cidambi provided her insight into how the long-standing inpatient detox protocol might not be the best course of action.Continue Reading →
New Jersey’s Lt. Governor, Kim Guadagno, visited the Center for Network Therapy to understand the ambulatory Detox model and find out how CNT is able to address the needs of individuals suffering from opiate withdrawal, benzo withdrawal and alcohol withdrawal. She was impressed by the efficacy of the program.Continue Reading →
FDA recently announced the approval of Probuphine, an implantable form of buprenorphine, for treating opioid dependence. National Public Radio sought the views of Dr. Cidambi, addiction expert and medical director of the Center for Network Therapy, on the medication.Continue Reading →
Dr. Oz’s online health site seeks addiction expert, Dr. Cidambi’s views on Probuphine, which was recently approved by the FDA. Probuphine is intended for treatment for opioid dependence and it is used to treat individuals suffering from opiate withdrawal and opiate cravings. Dr. Cidambi, Center for Network Therapy’s medical director argues why Probuphine will flop.
Addiction specialist, Dr. Indra Cidambi is an expert in treating women with addiction issues. She recognizes the unique challenges women face as they deal with addiction. The press release details her approach to treating women with substance use disorders and it was published in the Huffington Post and Psychology Today.Continue Reading →
With news from Florida that a young man killed two people while high on “Flakka” and tried to eat one of his victim’s face, the Rolling Stone magazine reached out to addiction expert, Dr. Cidambi, to understand the effects of abusing “Flakka.” What kind of high does it give? What can be expect of people high on “Flakka?”